Form 4 Filing for Axogen, Inc. - Insider Transaction

This SEC filing details a transaction by Alan M. Levine, a director at Axogen, Inc. On June 19, 2026, Levine acquired 14,150 shares of Common Stock through the vesting of restricted stock units. This transaction is part of his annual equity grant for serving on the Board of Directors. The value of the grant was based on a $150,000 valuation as of the grant date, and the shares vested one year later. Each restricted stock unit represents a contingent right to one share of Axogen, Inc. common stock. Following this transaction, Levine directly owns 50,893 shares of common stock.